370 related articles for article (PubMed ID: 28646109)
1. Bone morphogenetic protein 9 (BMP9) and BMP10 enhance tumor necrosis factor-α-induced monocyte recruitment to the vascular endothelium mainly via activin receptor-like kinase 2.
Mitrofan CG; Appleby SL; Nash GB; Mallat Z; Chilvers ER; Upton PD; Morrell NW
J Biol Chem; 2017 Aug; 292(33):13714-13726. PubMed ID: 28646109
[TBL] [Abstract][Full Text] [Related]
2. Bone morphogenetic protein (BMP) and activin type II receptors balance BMP9 signals mediated by activin receptor-like kinase-1 in human pulmonary artery endothelial cells.
Upton PD; Davies RJ; Trembath RC; Morrell NW
J Biol Chem; 2009 Jun; 284(23):15794-804. PubMed ID: 19366699
[TBL] [Abstract][Full Text] [Related]
3. Regulation of the ALK1 ligands, BMP9 and BMP10.
Li W; Salmon RM; Jiang H; Morrell NW
Biochem Soc Trans; 2016 Aug; 44(4):1135-41. PubMed ID: 27528761
[TBL] [Abstract][Full Text] [Related]
4. Endothelial protective factors BMP9 and BMP10 inhibit CCL2 release by human vascular endothelial cells.
Upton PD; Park JES; De Souza PM; Davies RJ; Griffiths MJD; Wort SJ; Morrell NW
J Cell Sci; 2020 Jul; 133(14):. PubMed ID: 32576665
[TBL] [Abstract][Full Text] [Related]
5. A heterodimer formed by bone morphogenetic protein 9 (BMP9) and BMP10 provides most BMP biological activity in plasma.
Tillet E; Ouarné M; Desroches-Castan A; Mallet C; Subileau M; Didier R; Lioutsko A; Belthier G; Feige JJ; Bailly S
J Biol Chem; 2018 Jul; 293(28):10963-10974. PubMed ID: 29789425
[TBL] [Abstract][Full Text] [Related]
6. Serum/glucocorticoid-regulated kinase 1 as a novel transcriptional target of bone morphogenetic protein-ALK1 receptor signaling in vascular endothelial cells.
Araki M; Hisamitsu T; Kinugasa-Katayama Y; Tanaka T; Harada Y; Nakao S; Hanada S; Ishii S; Fujita M; Kawamura T; Saito Y; Nishiyama K; Watanabe Y; Nakagawa O
Angiogenesis; 2018 May; 21(2):415-423. PubMed ID: 29478089
[TBL] [Abstract][Full Text] [Related]
7. BMP9, but not BMP10, acts as a quiescence factor on tumor growth, vessel normalization and metastasis in a mouse model of breast cancer.
Ouarné M; Bouvard C; Boneva G; Mallet C; Ribeiro J; Desroches-Castan A; Soleilhac E; Tillet E; Peyruchaud O; Bailly S
J Exp Clin Cancer Res; 2018 Aug; 37(1):209. PubMed ID: 30165893
[TBL] [Abstract][Full Text] [Related]
8. Bone Morphogenetic Protein 9 Enhances Lipopolysaccharide-Induced Leukocyte Recruitment to the Vascular Endothelium.
Appleby SL; Mitrofan CG; Crosby A; Hoenderdos K; Lodge K; Upton PD; Yates CM; Nash GB; Chilvers ER; Morrell NW
J Immunol; 2016 Oct; 197(8):3302-3314. PubMed ID: 27647829
[TBL] [Abstract][Full Text] [Related]
9. BMP9 and BMP10 are critical for postnatal retinal vascular remodeling.
Ricard N; Ciais D; Levet S; Subileau M; Mallet C; Zimmers TA; Lee SJ; Bidart M; Feige JJ; Bailly S
Blood; 2012 Jun; 119(25):6162-71. PubMed ID: 22566602
[TBL] [Abstract][Full Text] [Related]
10. Histone deacetylase inhibitor reduces monocyte adhesion to endothelium through the suppression of vascular cell adhesion molecule-1 expression.
Inoue K; Kobayashi M; Yano K; Miura M; Izumi A; Mataki C; Doi T; Hamakubo T; Reid PC; Hume DA; Yoshida M; Aird WC; Kodama T; Minami T
Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2652-9. PubMed ID: 17008592
[TBL] [Abstract][Full Text] [Related]
11. ZLJ-6, a novel COX/5-LOX inhibitor, attenuates TNF-α-induced endothelial E-selectin, ICAM-1 and VCAM-1 expression and monocyte-endothelial interactions via a COX/5-LOX-independent mechanism.
Chen L; Zhao Q; Wang XL; You R; Zhang YH; Ji H; Lai YS
Vascul Pharmacol; 2011; 55(5-6):135-42. PubMed ID: 21777697
[TBL] [Abstract][Full Text] [Related]
12. Specificity and structure of a high affinity activin receptor-like kinase 1 (ALK1) signaling complex.
Townson SA; Martinez-Hackert E; Greppi C; Lowden P; Sako D; Liu J; Ucran JA; Liharska K; Underwood KW; Seehra J; Kumar R; Grinberg AV
J Biol Chem; 2012 Aug; 287(33):27313-25. PubMed ID: 22718755
[TBL] [Abstract][Full Text] [Related]
13. Identification of BMP9 and BMP10 as functional activators of the orphan activin receptor-like kinase 1 (ALK1) in endothelial cells.
David L; Mallet C; Mazerbourg S; Feige JJ; Bailly S
Blood; 2007 Mar; 109(5):1953-61. PubMed ID: 17068149
[TBL] [Abstract][Full Text] [Related]
14. BMP9 (Bone Morphogenetic Protein-9)/Alk1 (Activin-Like Kinase Receptor Type I) Signaling Prevents Hyperglycemia-Induced Vascular Permeability.
Akla N; Viallard C; Popovic N; Lora Gil C; Sapieha P; Larrivée B
Arterioscler Thromb Vasc Biol; 2018 Aug; 38(8):1821-1836. PubMed ID: 29880487
[TBL] [Abstract][Full Text] [Related]
15. Luteolin protects against vascular inflammation in mice and TNF-alpha-induced monocyte adhesion to endothelial cells via suppressing IΚBα/NF-κB signaling pathway.
Jia Z; Nallasamy P; Liu D; Shah H; Li JZ; Chitrakar R; Si H; McCormick J; Zhu H; Zhen W; Li Y
J Nutr Biochem; 2015 Mar; 26(3):293-302. PubMed ID: 25577468
[TBL] [Abstract][Full Text] [Related]
16. Lipoxin A4 inhibits immune cell binding to salivary epithelium and vascular endothelium.
Chinthamani S; Odusanwo O; Mondal N; Nelson J; Neelamegham S; Baker OJ
Am J Physiol Cell Physiol; 2012 Apr; 302(7):C968-78. PubMed ID: 22205391
[TBL] [Abstract][Full Text] [Related]
17. A Bone Morphogenetic Protein (BMP)-derived Peptide Based on the Type I Receptor-binding Site Modifies Cell-type Dependent BMP Signalling.
Tong Z; Guo J; Glen RC; Morrell NW; Li W
Sci Rep; 2019 Sep; 9(1):13446. PubMed ID: 31530856
[TBL] [Abstract][Full Text] [Related]
18. Context-dependent signaling defines roles of BMP9 and BMP10 in embryonic and postnatal development.
Chen H; Brady Ridgway J; Sai T; Lai J; Warming S; Chen H; Roose-Girma M; Zhang G; Shou W; Yan M
Proc Natl Acad Sci U S A; 2013 Jul; 110(29):11887-92. PubMed ID: 23812757
[TBL] [Abstract][Full Text] [Related]
19. CRP promotes monocyte-endothelial cell adhesion via Fcgamma receptors in human aortic endothelial cells under static and shear flow conditions.
Devaraj S; Davis B; Simon SI; Jialal I
Am J Physiol Heart Circ Physiol; 2006 Sep; 291(3):H1170-6. PubMed ID: 16603696
[TBL] [Abstract][Full Text] [Related]
20. Molecular basis of ALK1-mediated signalling by BMP9/BMP10 and their prodomain-bound forms.
Salmon RM; Guo J; Wood JH; Tong Z; Beech JS; Lawera A; Yu M; Grainger DJ; Reckless J; Morrell NW; Li W
Nat Commun; 2020 Apr; 11(1):1621. PubMed ID: 32238803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
